Press Releases for stj

Press Releases
St. Jude Medical Reports Fourth Quarter and Full-Year 2009 Results
Caldera Medical Elects Board of Directors
Contingency-Fee Patent Cases Helping The Lanier Law Firm Fuel Growth in Palo Alto, Calif.
St. Jude Medical Reports Third Quarter 2009 Results
Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2009 Financial Results
Cambridge Heart Reports Results for the Second Quarter 2009
St. Jude Medical, Inc. Announces Pricing of Public Offering of Senior Debt
St. Jude Medical Announces Commencement of Public Offering of Senior Debt
St. Jude Medical Reports Second Quarter 2009 Results
St. Jude Medical Announces Completion of European Enrollment in its Trifecta Stented Tissue Valve Trial
St. Jude Medical Announces FDA Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Fitch Assigns an 'A' Rating to St. Jude Medical; Outlook Stable
St. Jude Medical Announces Australian TGA Regulatory Approval for Libra Deep Brain Stimulation Systems for Parkinson's Disease
St. Jude Medical Announces Second Quarter 2009 Earnings Conference Call
St. Jude Medical Applauds MADIT-CRT Trial
Kensey Nash Corporation Adopts Stockholder Rights Plan
St. Jude Medical Announces FDA Approval of the Cool Point Irrigation Pump
St. Jude Medical Announces Leading Sponsorship of Landmark Clinical Trial to Study Atrial Fibrillation
St. Jude Medical Announces Initial Implant of First-to-Market Connector System in the U.S.
St. Jude Medical Acquires Intellectual Property and Non-Cash Assets of Northstar Neuroscience, Inc.
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson’s Disease
LifeTech Capital Group Joins Jesup & Lamont
St. Jude Medical To Present at the William Blair & Company's 29th Annual Growth Stock Conference
Patients in St. Jude Medical Deep Brain Stimulation for Depression Pilot Study Demonstrate Sustained Improvement in Depression Symptoms
Cambridge Heart Reports Results for the First Quarter 2009
St. Jude Medical Announces Results From STAR-AF Trial
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, As Chief Executive Officer
St. Jude Medical to Highlight Comprehensive Arrhythmia Management Solutions and Electronic Health Record Connectivity at Heart Rhythm 2009
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
St. Jude Medical Announces European CE Mark Approval and First Use of Next-Generation Cardiac Mapping System
St. Jude Medical Announces European Approval of Its Newest Heart Failure Devices Which Enable More Efficient Implantation and Follow-up
CORRECTING and REPLACING St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to Provide Therapy for Life-Threatening Arrhythmias and Heart Failure
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to Provide Therapy for Life-Threatening Arrhythmias and Heart Failure
St. Jude Medical Announces Results of Shareholders’ Vote at Annual Meeting
St. Jude Medical Announces FDA Clearance and Launch of the Attune Annuloplasty Ring for Heart Valve Repair
St. Jude Medical to Present at Banc of America Securities Merrill Lynch 2009 Health Care Conference
Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
St. Jude Medical Reports First Quarter 2009 Results
ISWest and Neocomp Take Next Step and Develop Turnkey Solutions for Businesses
St. Jude Medical’s Merlin.net Patient Care Network Wins Medical Design Excellence Award
St. Jude Medical Announces First Quarter 2009 Earnings Conference Call
St. Jude Medical Announces First European Patient Implants of the Libra Deep Brain Stimulation Systems for Parkinson’s Disease
St. Jude Medical Announces FDA Approval of New Features in Remote Patient Care for Implantable Cardiac Devices
Zacks Analyst Blog Highlights: National Semiconductor Corp, Cosi Inc, Jamba Inc, Freddie Mac and St. Jude Medical.
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
St. Jude Medical To Present at Cowen and Company Healthcare Conference
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for the World’s Smallest and Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
St. Jude Medical Welcomes Introduction of Legislation to Help People Suffering From Pain
St. Jude Medical Announces U.S. Approval of Industry’s First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices
St. Jude Medical Announces 2009 Annual Investor Conference
BenchmarkJournal.Com (Complimentary) Analyst Review for WMS, AZN, STJ and MET
St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results
St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson’s Disease
Research and Markets: Republic of Korea Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 Report With Profiles of the Leading Companies
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
St. Jude Medical Announces First Use Outside the U.S. of Imaging System for Real-Time Views inside the Heart
FAME Study Published in New England Journal of Medicine
St. Jude Medical Announces Japanese Approval of Atlas II ICD
St. Jude Medical Announces Fourth Quarter and Full-Year 2008 Earnings Conference Call
Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Pfizer, St. Jude Medical, Inc. And eBay Inc.
St. Jude Medical Acquires MediGuide
St. Jude Medical Acquires Radi Medical Systems
BridgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on CNI, STJ, NCC and WFC
St. Jude Medical Announces Neuromodulation Division Name Change, Unveils New Brand Identity at 12th Annual North American Neuromodulation Society Meeting
St. Jude Medical Announces European Approval and Initial Implant of First Device to Continuously Monitor Electrical Changes That Signal Potential Cardiac Problems
St. Jude Medical Announces Launch of QuickOpt Timing Cycle Optimization for Cardiac Resynchronization Therapy Defibrillators (CRT-D) in Japan
St. Jude Medical To Present at Piper Jaffray 20th Annual “Unplugged” Health Care Conference
St. Jude Medical Announces Japanese Approval and Launch of Victory Family of Pacemakers
St. Jude Medical Announces Publication of 20-Year Durability Data on Tissue Heart Valve
Dorin Panescu Named NewCardio's Chief Technical Officer
SectorWatch.biz Issues MarketStats on NWCI, STJ, ERES, BEAT, MDT, and BSX
St. Jude Medical Reports Third Quarter Results
St. Jude Medical Announces U.S. and European Approval of Angio-Seal Evolution Vascular Closure Device
St. Jude Medical Announces European CE Mark Approval of Implantable Device for the Detection of Atrial Fibrillation and Other Abnormal Heart Rhythms
Zacks Analyst Blog Highlights: St. Jude Medical, Inc., Carmike Cinemas, Inc., The Washington Post Co., Avis Budget Group Inc. And Robert Half International Inc.
Zacks Bull and Bear of the Day Highlights: St. Jude Medical, AAR Corp., Sangamo Biosciences, State Auto Financial and Robert Half
St. Jude Medical Celebrates the 50th Anniversary of the World's First Implantable Pacemaker
St. Jude Medical Announces Third Quarter 2008 Earnings Conference Call
Analyst Reports for St. Jude Medical Inc., The Home Depot Inc., TrueBlue Inc. And MetLife Inc.
SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX
Former U.S. Army Parachutist Becomes First Person Implanted with the World's Smallest Neurostimulator to Treat Chronic Pain
St. Jude Medical Announces FDA Clearance of Implantable Device to Monitor Cardiac Conditions
St. Jude Medical To Present at Morgan Stanley Global Healthcare Unplugged Conference - Sep 2 2008 4:41PM
St. Jude Medical Announces FDA Approval of Arecibo Manufacturing Plant
St. Jude Medical Announces CE Mark Approval and FDA Clearance for New Family of HIFU Surgical Ablation Products
St. Jude Medical Receives U.S. and European Approvals of EonC, the First Extended-Life Primary Cell Neurostimulator for the Treatment of Chronic Pain
Datascope Sells Vascular Closure Assets of Its Interventional Products Business
St. Jude Medical Announces Japanese Approval of the Durata Defibrillation Lead
St. Jude Medical Reports Second Quarter Results
St. Jude Medical Announces FDA Approval of Wireless Transmitter to Monitor Patients' Implanted Cardiac Devices
St. Jude Medical Announces CE Mark Approval and European Launch of HydroSteer Guidewire Line with Hydrophilic Coating
St. Jude Medical Completes Acquisition of EP MedSystems and Announces Final Prorated Results of EP MedSystems Shareholder Cash/Stock Elections
CORRECTING and REPLACING St. Jude Medical and EP MedSystems Announce Final Exchange Ratio for Pending Acquisition
St. Jude Medical and EP MedSystems Announce Final Exchange Ratio for Pending Acquisition
St. Jude Medical Announces Second Quarter 2008 Earnings Conference Call
St. Jude Medical and EP MedSystems Announce Cash/Stock Election Deadline and Expected Closing Date of Pending Acquisition
St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
St. Jude Medical Announces CE Mark Approval and European Launch of TigerWire Steerable Guidewire
Results from Studies Evaluating High-Voltage Lead Performance Presented at Heart Rhythm Society's 29th Annual Scientific Sessions - May 27 2008 12:54AM
St. Jude Medical Announces FDA Clearance and European CE Mark Approval for Tools That Help Place Leads in Challenging Heart Anatomy - May 27 2008 12:54AM